Promutech Pharmaceuticals, Inc.

Promutech Pharmaceuticals, Inc., is working on an FLT3 inhibitor technology. The inventors expect to license the technology to their new startup within the fiscal year. CEO: Neil Shah, MD, PhD.
Team: 
Hong Yu Li
Brendan Frett